May 21, 2025, 2:01 PM
May 20, 2025, 1:57 PM
Hemanext names Geoff Crouse to board of directors
- Flexential appointed Paul Szurek and Andy Stewart to its Board of Directors to enhance its leadership team.
- Both members bring extensive experience in data centers and enterprise IT solutions.
- The board expansion aims to support Flexential's growth in response to increasing demand for digital infrastructure.
In the United States on May 21, 2025, Hemanext Inc. has appointed Geoff Crouse to its Board of Directors, expanding the company's leadership team. With over 25 years of experience in the life sciences industry, Crouse's appointment comes as Hemanext focuses on innovation in blood processing and transfusion technology. Crouse has previously held prominent roles, including CEO of Candela Medical, and played a key role in high-profile acquisitions in his career. His leadership is anticipated to enhance the strategic direction and operational capabilities of Hemanext amidst an evolving market.
Opinions
You've reached the end